Marco Perez

5.0/5

6 Patient Ratings

90 Patient Reviews

Marco Perez

Cardiac electrophysiologist

Associate Professor of Medicine (Cardiovascular Medicine)

View Professional Summary

Additional Languages Spoken:

French , Spanish

Insurance Coverage

Online Second Opinion Program

Resources for Referring Physicians

Biography

Dr. Marco Perez's research goal is to better understand the fundamental causes of cardiovascular disease through the study of genetics and epidemiology. His group studies the genetic variations and environmental exposures that are associated with conditions such as atrial fibrillation and heart failure. He has led the studies of atrial fibrillation in Women's Health Initiative, one of the largest nation-wide population-based cohorts. He is currently conducting a large study monitoring for silent or asymptomatic atrial fibrillation in women from the WHI randomized to exercise intervention, and was co-PI of the Apple Heart Study, a clinical trial that validated the ability of a smartwatch to detect atrial fibrillation. He is now PI of the Clinical Coordinating Center at Stanford for the REACT-AF which is a clinical trial to evaluate efficacy and safety of a "pill-in-the pocket" approach to anticoagulation for AF using a smartwatch. He is interested in understanding the paradox that atrial fibrillation is less common in African Americans and Hispanics, despite a greater burden of risk factors such as hypertension. As director of the Stanford Inherited Arrhythmia Clinic, he evaluates families with rare inherited arrhythmias associated with sudden death such as Long QT and Brugada Syndromes and explores their links with novel genes. He also studies the genetic causes of very early onset atrial fibrillation. He also studies how best to use the electrocardiogram and imaging modalities using Machine Learning techniques to identify patients at risk for cardiovascular disease. Dr. Perez receives funding from the NIH/NHLBI, Apple Inc., Janssen and the Colson Foundation.

View Full Biography

Professional Summary

Education & Certifications

Board Certification: American Board of Internal Medicine, Clinical Cardiac Electrophysiology (2011)
Fellowship: Stanford University Medical Center (2010) CA
Fellowship: Stanford University School of Medicine (2007) CA

Residency: Massachusetts General Hospital (2004) MA

Internship: Massachusetts General Hospital (2002) MA

Medical Education: Harvard University Health Services (2001) MA

Fellowship, Stanford, Electrophysiology (2010)

Fellowship, Stanford, Cardiology (2007)

Residency, Massachusetts General Hospital, Internal Medicine (2004)

Honors & Awards

Dean's Fellow Research Award, Stanford University (2006-2008)
Department of Medicine Teaching Award, Stanford University (2014)
Fellow to Faculty Award, American Heart Association (2011-2016)

Finalist, FGTB Young Investigator Award, American Heart Association (2013)

Harold Amos Faculty Development Award, Robert Wood Johnson Foundation (2012-2016)

Loan Repayment Program Award, NIH (2010-2014)

National Research Service Award, NIH (2006-2008)

R01 Research Project Grant (1R01HL136390-01 ), NIH/NHLBI (2017-2022)

SPARK Award, Stanford University (2014-2015)

Memberships

Member, AHA Research Committee (2014 - Present)
Medical Director, Racing Hearts Community AED Program (2014 - Present)

Administrative Appointments

Director, Stanford Inherited Cardiac Arrhythmia Clinic (2013 - Present)
Director, Stanford Cardiac Electrocardiography Laboratory (2017 - Present)

Publications

Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy
Haddad, F., Perez, M., Fleischmann, D., Valantine, H., & Hunt, S. A. (2006). Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(11), 1367–70.
Prognostic value of the computerized ECG in Hispanics
Perez, M. V., Yaw, T. S., Myers, J., & Froelicher, V. F. (2007). Prognostic value of the computerized ECG in Hispanics. CLINICAL CARDIOLOGY, 30(4), 189–94.
Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery
Bravata, D. M., Gienger, A. L., McDonald, K. M., Sundaram, V., Perez, M. V., Varghese, R., … Hlatky, M. A. (2007). Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. ANNALS OF INTERNAL MEDICINE, 147(10), 703–U139.

Statin Use and Ventricular Arrhythmias During Clinical Treadmill Testing
Dewey, F. E., Perez, M., Hadley, D., Freeman, J. V., Wang, P., Ashley, E. A., … Froelicher, V. F. (2009). Statin Use and Ventricular Arrhythmias During Clinical Treadmill Testing. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 20(2), 193–99.

Added Value of a Resting ECG Neural Network That Predicts Cardiovascular Mortality
Perez, M. V., Dewey, F. E., Tan, S. Y., Myers, J., & Froelicher, V. F. (2009). Added Value of a Resting ECG Neural Network That Predicts Cardiovascular Mortality. ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 14(1), 26–34.

Isolated Disease of the Proximal Left Anterior Descending Artery Comparing the Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Surgery
Kapoor, J. R., Gienger, A. L., Ardehali, R., Varghese, R., Perez, M. V., Sundaram, V., … Bravata, D. M. (2008). Isolated Disease of the Proximal Left Anterior Descending Artery Comparing the Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Surgery. JACC-CARDIOVASCULAR INTERVENTIONS, 1(5), 483–91.

Mechanisms of exercise intolerance in patients with hypertrophic cardiomyopathy
Le, V.-V., Perez, M. V., Wheeler, M. T., Myers, J., Schnittger, I., & Ashley, E. A. (2009). Mechanisms of exercise intolerance in patients with hypertrophic cardiomyopathy. AMERICAN HEART JOURNAL, 158(3), E27–E34.

Electrocardiographic predictors of atrial fibrillation
Perez, M. V., Dewey, F. E., Marcus, R., Ashley, E. A., Al-Ahmad, A. A., Wang, P. J., & Froelicher, V. F. (2009). Electrocardiographic predictors of atrial fibrillation. AMERICAN HEART JOURNAL, 158(4), 622–28.

Adding an Electrocardiogram to the Pre-participation Examination in Competitive Athletes: A Systematic Review
Perez, M., Fonda, H., Le, V.-V., Mitiku, T., Ray, J., Freeman, J. V., … Froelicher, V. F. (2009). Adding an Electrocardiogram to the Pre-participation Examination in Competitive Athletes: A Systematic Review. CURRENT PROBLEMS IN CARDIOLOGY, 34(12), 586–662.

Addition of the Electrocardiogram to the Preparticipation Examination of College Athletes
Le, V.-V., Wheeler, M. T., Mandic, S., Dewey, F., Fonda, H., Perez, M., … Froelicher, V. (2010). Addition of the Electrocardiogram to the Preparticipation Examination of College Athletes. CLINICAL JOURNAL OF SPORT MEDICINE, 20(2), 98–105.

Inappropriate pacing in a patient with managed ventricular pacing: What is the cause?
Perez, M. V., Al-Ahmad, A. A., Wang, P. J., & Turakhia, M. P. (2010). Inappropriate pacing in a patient with managed ventricular pacing: What is the cause? HEART RHYTHM, 7(9), 1336–37.

Genetics of Arrhythmia: Disease Pathways Beyond Ion Channels
Perez, M. V., Wheeler, M., Ho, M., Pavlovic, A., Wang, P., & Ashley, E. A. (2008). Genetics of Arrhythmia: Disease Pathways Beyond Ion Channels. JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 1(2), 155–65.

Gene Coexpression Network Topology of Cardiac Development, Hypertrophy, and Failure
Dewey, F. E., Perez, M. V., Wheeler, M. T., Watt, C., Spin, J., Langfelder, P., … Ashley, E. A. (2011). Gene Coexpression Network Topology of Cardiac Development, Hypertrophy, and Failure. CIRCULATION-CARDIOVASCULAR GENETICS, 4(1), 26–U129.

Cost-Effectiveness of Genetic Testing in Family Members of Patients With Long-QT Syndrome
Perez, M. V., Kumarasamy, N. A., Owens, D. K., Wang, P. J., & Hlatky, M. A. (2011). Cost-Effectiveness of Genetic Testing in Family Members of Patients With Long-QT Syndrome. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 4(1), 76–84.

Interpretation of the Electrocardiogram of Young Athletes
Uberoi, A., Stein, R., Perez, M. V., Freeman, J., Wheeler, M., Dewey, F., … Froelicher, V. (2011). Interpretation of the Electrocardiogram of Young Athletes. CIRCULATION, 124(6), 746–57.

The Impact of ST Elevation on Athletic Screening
Leo, T., Uberoi, A., Jain, N. A., Garza, D., Chowdhury, S., Freeman, J. V., … Froelicher, V. (2011). The Impact of ST Elevation on Athletic Screening. CLINICAL JOURNAL OF SPORT MEDICINE, 21(5), 433–40.

Early Repolarization in an Ambulatory Clinical Population
Uberoi, A., Jain, N. A., Perez, M., Weinkopff, A., Ashley, E., Hadley, D., … Froelicher, V. (2011). Early Repolarization in an Ambulatory Clinical Population. CIRCULATION, 124(20), 2208–14.

The prognostic value of early repolarization with ST-segment elevation in African Americans
Perez, M. V., Uberoi, A., Jain, N. A., Ashley, E., Turakhia, M. P., & Froelicher, V. (2012). The prognostic value of early repolarization with ST-segment elevation in African Americans. HEART RHYTHM, 9(4), 558–65.

Catheter ablation of atrial fibrillation: state-of-the-art techniques and future perspectives
Santangeli, P., Di Biase, L., Burkhardt, D. J., Horton, R., Sanchez, J., Bai, R., … Al-Ahmad, A. (2012). Catheter ablation of atrial fibrillation: state-of-the-art techniques and future perspectives. JOURNAL OF CARDIOVASCULAR MEDICINE, 13(2), 108–124.

Semantic Confusion: The Case of Early Repolarization and the J Point
Perez, M. V., Friday, K., & Froelicher, V. (2012). Semantic Confusion: The Case of Early Repolarization and the J Point. AMERICAN JOURNAL OF MEDICINE, 125(9), 843–44.

Use and overuse of left ventriculography
Witteles, R. M., Knowles, J. W., Perez, M., Morris, W. M., Spettell, C. M., Brennan, T. A., & Heidenreich, P. A. (2012). Use and overuse of left ventriculography. AMERICAN HEART JOURNAL, 163(4), 617-?

Prognostic Implications of Q Waves and T-Wave Inversion Associated With Early Repolarization
Uberoi, A., Sallam, K., Perez, M., Jain, N. A., Ashley, E., & Froelicher, V. (2012). Prognostic Implications of Q Waves and T-Wave Inversion Associated With Early Repolarization. MAYO CLINIC PROCEEDINGS, 87(7), 614–19.

Effects of Postmenopausal Hormone Therapy on Incident Atrial Fibrillation The Women's Health Initiative Randomized Controlled Trials
Perez, M. V., Wang, P. J., Larson, J. C., Virnig, B. A., Cochrane, B., Curb, J. D., … Stefanick, M. L. (2012). Effects of Postmenopausal Hormone Therapy on Incident Atrial Fibrillation The Women's Health Initiative Randomized Controlled Trials. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 5(6), 1108–16.

From bedside to bench
Perez, M., & Froelicher, V. (2013). From bedside to bench. JOURNAL OF ELECTROCARDIOLOGY, 46(2), 114–15.

Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study.
Perez, M. V., Wang, P. J., Larson, J. C., Soliman, E. Z., Limacher, M., Rodriguez, B., … Stefanick, M. L. (2013). Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study. Heart , 99(16), 1173–78.

p300/MDM2 complexes participate in MDM2-mediated p53 degradation
Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z. X., … Livingston, D. M. (1998). p300/MDM2 complexes participate in MDM2-mediated p53 degradation. MOLECULAR CELL, 2(4), 405–415.

Personalized Medicine and Cardiovascular Disease: From Genome to Bedside
Personalized Medicine and Cardiovascular Disease: From Genome to Bedside. (2011). Current Cardiovascular Risk Reports, 5.

Taming Rare Variation With Known Biology in Long QT Syndrome.
Perez, M. V., & Ashley, E. A. (2013). Taming Rare Variation With Known Biology in Long QT Syndrome. Circulation. Cardiovascular Genetics, 6(3), 227–229.

Prognostic implications of the J wave ECG patterns.
Yong, C. M., Perez, M., & Froelicher, V. (2013). Prognostic implications of the J wave ECG patterns. Journal of Electrocardiology, 46(5), 408–10.

J wave patterns and their prognostic value in African Americans.
Perez, M. V., & Froelicher, V. (2013). J wave patterns and their prognostic value in African Americans. Journal of Electrocardiology, 46(5), 442–45.

African American race but not genome-wide ancestry is negatively associated with atrial fibrillation among postmenopausal women in the Women's Health Initiative.
Perez, M. V., Hoffmann, T. J., Tang, H., Thornton, T., Stefanick, M. L., Larson, J. C., … Risch, N. (2013). African American race but not genome-wide ancestry is negatively associated with atrial fibrillation among postmenopausal women in the Women's Health Initiative. American Heart Journal, 166(3), 566–72.

Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation?
Abraham, J. E. M., Larson, J., Chung, M. K., Curtis, A. B., Lakshminarayan, K., Newman, J. D., … Wassertheil-Smoller, S. (2013). Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation? American Journal of Medicine, 126(12), 1143 e1–8.

Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative.
Hlatky, M. A., Ray, R. M., Burwen, D. R., Margolis, K. L., Johnson, K. C., Kucharska-Newton, A., … Stefanick, M. L. (2014). Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circulation. Cardiovascular Quality and Outcomes, 7(1), 157–62.

Prevalence and clinical correlates of right ventricular dysfunction in patients with hypertrophic cardiomyopathy.
Finocchiaro, G., Knowles, J. W., Pavlovic, A., Perez, M., Magavern, E., Sinagra, G., … Ashley, E. A. (2014). Prevalence and clinical correlates of right ventricular dysfunction in patients with hypertrophic cardiomyopathy. American Journal of Cardiology, 113(2), 361–67.

Exercise capacity and paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
Azarbal, F., Singh, M., Finocchiaro, G., Le, V.-V., Schnittger, I., Wang, P., … Perez, M. (2014). Exercise capacity and paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy. Heart , 100(8), 624–30.

Patterns and prognosis of all components of the J-wave pattern in multiethnic athletes and ambulatory patients.
Muramoto, D., Yong, C. M., Singh, N., Aggarwal, S., Perez, M., Ashley, E., … Froelicher, V. (2014). Patterns and prognosis of all components of the J-wave pattern in multiethnic athletes and ambulatory patients. American Heart Journal, 167(2), 259–66.

Different patterns of bundle-branch blocks and the risk of incident heart failure in the Women's Health Initiative (WHI) study.
Zhang, Z.-M., Rautaharju, P. M., Soliman, E. Z., Manson, J. A. E., Martin, L. W., Perez, M., … Prineas, R. J. (2013). Different patterns of bundle-branch blocks and the risk of incident heart failure in the Women's Health Initiative (WHI) study. Circulation. Heart Failure, 6(4), 655–661.

Variation in Use of Left Ventriculography in the Veterans Affairs Health Care System
Heidenreich, P. A., Lin, S., Knowles, J. W., Perez, M., Maddox, T. M., Ho, M. P., … Witteles, R. M. (2013). Variation in Use of Left Ventriculography in the Veterans Affairs Health Care System. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 6(6), 687–93.

Latent obstruction and left atrial size are predictors of clinical deterioration leading to septal reduction in hypertrophic cardiomyopathy.
Finocchiaro, G., Haddad, F., Pavlovic, A., Sinagra, G., Schnittger, I., Knowles, J. W., … Ashley, E. (2014). Latent obstruction and left atrial size are predictors of clinical deterioration leading to septal reduction in hypertrophic cardiomyopathy. Journal of Cardiac Failure, 20(4), 236–43.

Molecular diagnosis of long QT syndrome at 10 days of life by rapid whole genome sequencing.
Priest, J. R., Ceresnak, S. R., Dewey, F. E., Malloy-Walton, L. E., Dunn, K., Grove, M. E., … Ashley, E. A. (2014). Molecular diagnosis of long QT syndrome at 10 days of life by rapid whole genome sequencing. Heart Rhythm , 11(10), 1707–13.

Electrocardiographic Repolarization-Related Variables as Predictors of Coronary Heart Disease Death in the Women's Health Initiative Study.
Rautaharju, P. M., Zhang, Z.-M., Vitolins, M., Perez, M., Allison, M. A., Greenland, P., & Soliman, E. Z. (2014). Electrocardiographic Repolarization-Related Variables as Predictors of Coronary Heart Disease Death in the Women's Health Initiative Study. Journal of the American Heart Association, 3(4).

Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women.
Azarbal, F., Stefanick, M. L., Salmoirago-Blotcher, E., Manson, J. A. E., Albert, C. M., LaMonte, M. J., … Perez, M. V. (2014). Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. Journal of the American Heart Association, 3(4).

Evidence of Heterogeneity by Race/Ethnicity in Genetic Determinants of QT Interval.
Seyerle, A. A., Young, A. M., Jeff, J. M., Melton, P. E., Jorgensen, N. W., Lin, Y., … Avery, C. L. (2014). Evidence of Heterogeneity by Race/Ethnicity in Genetic Determinants of QT Interval. Epidemiology (Cambridge, Mass.), 25(6), 790–8.

P-Wave Characteristics on Routine Preoperative Electrocardiogram Improve Prediction of New-Onset Postoperative Atrial Fibrillation in Cardiac Surgery
Wong, J. K., Lobato, R. L., Pinesett, A., Maxwell, B. G., Mora-Mangano, C. T., & Perez, M. V. (2014). P-Wave Characteristics on Routine Preoperative Electrocardiogram Improve Prediction of New-Onset Postoperative Atrial Fibrillation in Cardiac Surgery. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 28(6), 1497–1504.

Association Between Success Rate and Citation Count of Studies of Radiofrequency Catheter Ablation for Atrial Fibrillation Possible Evidence of Citation Bias
Perino, A. C., Hoang, D. D., Holmes, T. H., Santangeli, P., Heidenreich, P. A., Perez, M. V., … Turakhia, M. P. (2014). Association Between Success Rate and Citation Count of Studies of Radiofrequency Catheter Ablation for Atrial Fibrillation Possible Evidence of Citation Bias. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 7(5), 687–92.

Evidence of Heterogeneity by Race/Ethnicity in Genetic Determinants of QT Interval
Seyerle, A. A., Young, A. M., Jeff, J. M., Melton, P. E., Jorgensen, N. W., Lin, Y., … Avery, C. L. (2014). Evidence of Heterogeneity by Race/Ethnicity in Genetic Determinants of QT Interval. EPIDEMIOLOGY, 25(6), 790–98.

Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment.
Finocchiaro, G., Haddad, F., Knowles, J. W., Caleshu, C., Pavlovic, A., Homburger, J., … Ashley, E. A. (2015). Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment. JACC. Heart Failure, 3(5), 408–18.

Limitations of Current AHA Guidelines and Proposal of New Guidelines for the Preparticipation Examination of Athletes
Dunn, T. P., Pickham, D., Aggarwal, S., Saini, D., Kumar, N., Wheeler, M. T., … Froelicher, V. F. (2015). Limitations of Current AHA Guidelines and Proposal of New Guidelines for the Preparticipation Examination of Athletes. CLINICAL JOURNAL OF SPORT MEDICINE, 25(6), 472–77.

Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High-risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF)
Turakhia, M. P., Ullal, A. J., Hoang, D. D., Than, C. T., Miller, J. D., Friday, K. J., … Heidenreich, P. A. (2015). Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High-risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF). CLINICAL CARDIOLOGY, 38(5), 285–92.

Pacemaker Therapy in Atrial Fibrillation
Park, S., Wang, P. J., Zei, P. C., Hsia, H. H., Turakhi, M., Perez, M. V., & Al-Ahmad, A. A. (2013). Pacemaker Therapy in Atrial Fibrillation. Journal of Cardiology and Vascular Medicine, 1.

Systematic Comparison of Digital Electrocardiograms From Healthy Athletes and Patients With Hypertrophic Cardiomyopathy.
Bent, R. E., Wheeler, M. T., Hadley, D., Knowles, J. W., Pavlovic, A., Finocchiaro, G., … Perez, M. V. (2015). Systematic Comparison of Digital Electrocardiograms From Healthy Athletes and Patients With Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology, 65(22), 2462–63.

Race and ethnicity, obesity, metabolic health, and risk of cardiovascular disease in postmenopausal women.
Schmiegelow, M. D., Hedlin, H., Mackey, R. H., Martin, L. W., Vitolins, M. Z., Stefanick, M. L., … Hlatky, M. A. (2015). Race and ethnicity, obesity, metabolic health, and risk of cardiovascular disease in postmenopausal women. Journal of the American Heart Association, 4(5).

Computerized Q wave dimensions in athletes and hypertrophic cardiomyopathy patients
Bent, R. E., Wheeler, M. T., Hadley, D., Froelicher, V., Ashley, E., & Perez, M. V. (2015). Computerized Q wave dimensions in athletes and hypertrophic cardiomyopathy patients. JOURNAL OF ELECTROCARDIOLOGY, 48(3), 362–67.

Lean body mass and risk of incident atrial fibrillation in post-menopausal women
Azarbal, F., Stefanick, M. L., Assimes, T. L., Manson, J. A. E., Bea, J. W., Li, W., … Perez, M. V. (2016). Lean body mass and risk of incident atrial fibrillation in post-menopausal women. EUROPEAN HEART JOURNAL, 37(20), 1606–13.

Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis.
Shiffman, D., Perez, M. V., Bare, L. A., Louie, J. Z., Arellano, A. R., & Devlin, J. J. (2015). Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis. BMC Cardiovascular Disorders, 15, 104-?

Reply to van Oosten et al: "P-Wave Characteristics on Routine Preoperative Electrocardiogram Improve Prediction of New-Onset Postoperative Atrial Fibrillation in Cardiac Surgery".
Wong, J. K., Maxwell, B. G., & Perez, M. V. (2015). Reply to van Oosten et al: "P-Wave Characteristics on Routine Preoperative Electrocardiogram Improve Prediction of New-Onset Postoperative Atrial Fibrillation in Cardiac Surgery". Journal of Cardiothoracic and Vascular Anesthesia, 29(5), e63–4.

Association between success rate and citation count of studies of radiofrequency catheter ablation for atrial fibrillation: possible evidence of citation bias.
Perino, A. C., Hoang, D. D., Holmes, T. H., Santangeli, P., Heidenreich, P. A., Perez, M. V., … Turakhia, M. P. (2014). Association between success rate and citation count of studies of radiofrequency catheter ablation for atrial fibrillation: possible evidence of citation bias. Circulation. Cardiovascular Quality and Outcomes, 7(5), 687–92.

Gender Differences in Ventricular Remodeling and Function in College Athletes, Insights from Lean Body Mass Scaling and Deformation Imaging
Giraldeau, G., Kobayashi, Y., Finocchiaro, G., Wheeler, M., Perez, M., Kuznetsova, T., … Haddad, F. (2015). Gender Differences in Ventricular Remodeling and Function in College Athletes, Insights from Lean Body Mass Scaling and Deformation Imaging. AMERICAN JOURNAL OF CARDIOLOGY, 116(10), 1610–16.

Long-Term Prognosis of Early Repolarization With J-Wave and QRS Slur Patterns on the Resting Electrocardiogram: A Cohort Study.
Pargaonkar, V. S., Perez, M. V., Jindal, A., Mathur, M. B., Myers, J., & Froelicher, V. F. (2015). Long-Term Prognosis of Early Repolarization With J-Wave and QRS Slur Patterns on the Resting Electrocardiogram: A Cohort Study. Annals of Internal Medicine, 163(10), 747–55.

Systems Genomics Identifies a Key Role for Hypocretin/Orexin Receptor-2 in Human Heart Failure
Perez, M. V., Pavlovic, A., Shang, C., Wheeler, M. T., Miller, C. L., Liu, J., … Ashley, E. A. (2015). Systems Genomics Identifies a Key Role for Hypocretin/Orexin Receptor-2 in Human Heart Failure. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(22), 2522–33.

The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women.
Ermakov, S., Azarbal, F., Stefanick, M. L., LaMonte, M. J., Li, W., Tharp, K. M., … Perez, M. V. (2016). The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women. Heart , 102(17), 1354–62.

Racial and ethnic differences in atrial fibrillation risk factors and predictors in women: Findings from the Women's Health Initiative
Rodriguez, F., Stefanick, M. L., Greenland, P., Soliman, E. Z., Manson, J. A. E., Parikh, N., … Perez, M. V. (2016). Racial and ethnic differences in atrial fibrillation risk factors and predictors in women: Findings from the Women's Health Initiative. AMERICAN HEART JOURNAL, 176, 70–77.

Optimizing QT Interval Measurement for the Preparticipation Screening of Young Athletes.
Pickham, D., Hsu, D., Soofi, M., Goldberg, J. M., Saini, D., Hadley, D., … Froelicher, V. F. (2016). Optimizing QT Interval Measurement for the Preparticipation Screening of Young Athletes. Medicine and Science in Sports and Exercise, 48(9), 1745–50.

Early somatic mosaicism is a rare cause of long-QT syndrome
Priest, J. R., Gawad, C., Kahlig, K. M., Yu, J. K., O'Hara, T., Boyle, P. M., … Ashley, E. A. (2016). Early somatic mosaicism is a rare cause of long-QT syndrome. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 113(41), 11555–60.

Left atrial function and phenotypes in asymmetric hypertrophic cardiomyopathy.
Kobayashi, Y., Wheeler, M., Finocchiaro, G., Ariyama, M., Kobayashi, Y., Perez, M. V., … Haddad, F. (2017). Left atrial function and phenotypes in asymmetric hypertrophic cardiomyopathy. Echocardiography (Mount Kisco, N.Y.).

International criteria for electrocardiographic interpretation in athletes.
Drezner, J. A., Sharma, S., Baggish, A., Papadakis, M., Wilson, M. G., Prutkin, J. M., … Corrado, D. (2017). International criteria for electrocardiographic interpretation in athletes. British Journal of Sports Medicine.

Orexin: a Missing Link Between Sleep Disorders and Heart Failure?
Pan, S., Cabral, C. S., Ashley, E. A., & Perez, M. V. (2017). Orexin: a Missing Link Between Sleep Disorders and Heart Failure? Current Heart Failure Reports.

Whole Exome Sequencing in Atrial Fibrillation
Lubitz, S. A., Brody, J. A., Bihlmeyer, N. A., Roselli, C., Weng, L.-C., Christophersen, I. E., … Lin, H. (2016). Whole Exome Sequencing in Atrial Fibrillation. PLOS GENETICS, 12(9).

International Recommendations for Electrocardiographic Interpretation in Athletes.
Sharma, S., Drezner, J. A., Baggish, A., Papadakis, M., Wilson, M. G., Prutkin, J. M., … Corrado, D. (2017). International Recommendations for Electrocardiographic Interpretation in Athletes. Journal of the American College of Cardiology, 69(8), 1057–75.

Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease
Ullal, A. J., Kaiser, D. W., Fan, J., Schmitt, S. K., Than, C. T., Winkelmayer, W. C., … Turakhia, M. P. (2017). Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 28(1), 39–48.

The Associations of Atrial Fibrillation With the Risks of Incident Invasive Breast and Colorectal Cancers
Wassertheil-Smoller, S., McGinn, A. P., Martin, L., Rodriguez, B. L., Stefanick, M. L., & Perez, M. (2017). The Associations of Atrial Fibrillation With the Risks of Incident Invasive Breast and Colorectal Cancers. AMERICAN JOURNAL OF EPIDEMIOLOGY, 185(5), 372–84.

International Recommendations for Electrocardiographic Interpretation in Athletes
Sharma, S., Drezner, J. A., Baggish, A., Papadakis, M., Wilson, M. G., Prutkin, J. M., … Corrado, D. (2017). International Recommendations for Electrocardiographic Interpretation in Athletes. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(8), 1057–75.

Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation.
Christophersen, I. E., Rienstra, M., Roselli, C., Yin, X., Geelhoed, B., Barnard, J., … Ellinor, P. T. (2017). Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nature Genetics, 49(6), 946–52.

Athletic Remodeling in Female College Athletes, the "Morganroth Hypothesis" Revisited.
Kooreman, Z., Giraldeau, G., Finocchiaro, G., Kobayashi, Y., Wheeler, M., Perez, M., … Haddad, F. (2018). Athletic Remodeling in Female College Athletes, the "Morganroth Hypothesis" Revisited. Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine.

Large Q and S waves in lead III on the electrocardiogram distinguish patients with hypertrophic cardiomyopathy from athletes.
Chen, A. S., Bent, R. E., Wheeler, M., Knowles, J. W., Haddad, F., Froelicher, V., … Perez, M. V. (2018). Large Q and S waves in lead III on the electrocardiogram distinguish patients with hypertrophic cardiomyopathy from athletes. Heart (British Cardiac Society).

Ring Finger Protein 207 Degrades T613M Kv11.1 Channel
Ledford, H. A., Park, S., Sirish, P., Xu, W., Emigh, A. M., Timofeyev, V., … Chiamvimonvat, N. (2018). Ring Finger Protein 207 Degrades T613M Kv11.1 Channel. BIOPHYSICAL JOURNAL. CELL PRESS.

Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval.
Lin, H., van Setten, J., Smith, A. V., Bihlmeyer, N. A., Warren, H. R., Brody, J. A., … Isaacs, A. (2018). Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval. Circulation. Genomic and Precision Medicine, 11(5), e002037.

ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals
Bihlmeyer, N. A., Brody, J. A., Smith, A. V., Warren, H. R., Lin, H., Isaacs, A., … Sotoodehnia, N. (2018). ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals. CIRCULATION-CARDIOVASCULAR GENETICS, 11(1).

Genome Editing of Induced PluripotentStem Cells to Decipher CardiacChannelopathy Variant.
Garg, P., Oikonomopoulos, A., Chen, H., Li, Y., Lam, C. K., Sallam, K., … Wu, J. C. (2018). Genome Editing of Induced PluripotentStem Cells to Decipher CardiacChannelopathy Variant. Journal of the American College of Cardiology, 72(1), 62–75.

Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with Diabetes and Coronary Disease
Pallisgaard, J. L., Brooks, M. M., Chaitman, B. R., Boothroyd, D. B., Pere, M., & Hlatk, M. A. (2018). Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with Diabetes and Coronary Disease. AMERICAN JOURNAL OF MEDICINE, 131(7), 805–12.

Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6
Prins, B. P., Mead, T. J., Brody, J. A., Sveinbjornsson, G., Ntalla, I., Bihlmeyer, N. A., … Jamshidi, Y. (2018). Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6. GENOME BIOLOGY, 19, 87.

Effects of reproductive period duration and number of pregnancies on midlife ECG indices: a secondary analysis from the Women's Health Initiative Clinical Trial
Parikh, N. I., Kapphahn, K., Hedlin, H., Olgin, J. E., Allison, M. A., Magnani, J. W., … Howard, B. V. (2018). Effects of reproductive period duration and number of pregnancies on midlife ECG indices: a secondary analysis from the Women's Health Initiative Clinical Trial. BMJ OPEN, 8(8), e019129.

Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
Lee, S.-P., Ashley, E. A., Homburger, J., Caleshu, C., Green, E. M., Jacoby, D., … Perez, M. V. (2018). Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy. Circulation. Heart Failure, 11(9), e005191.

Genome-wide association study of heart rate and its variability in Hispanic/Latino cohorts
Kerr, K. F., Avery, C. L., Lin, H. J., Raffield, L. M., Zhang, Q. S., Browning, B. L., … Whitsel, E. A. (2017). Genome-wide association study of heart rate and its variability in Hispanic/Latino cohorts. HEART RHYTHM, 14(11), 1675–84.

Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.
Chen, L. Y., Chung, M. K., Allen, L. A., Ezekowitz, M., Furie, K. L., McCabe, P., … Turakhia, M. P. (2018). Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association. Circulation, 137(20), e623–e644.

Video-assisted thoracoscopic surgery to displace the phrenic nerve during endocardial ablation of right atrial tachycardia.
Mesquita, J., Bisla, J., Lee, A., & Perez, M. (2018). Video-assisted thoracoscopic surgery to displace the phrenic nerve during endocardial ablation of right atrial tachycardia. HeartRhythm Case Reports, 4(7), 304–6.

The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association.
Musunuru, K., Ingelsson, E., Fornage, M., Liu, P., Murphy, A. M., Newby, L. K., … Woo, D. (2017). The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association. Circulation. Cardiovascular Genetics, 10(4).

Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study.
Turakhia, M. P., Desai, M., Hedlin, H., Rajmane, A., Talati, N., Ferris, T., … Perez, M. V. (2018). Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study. American Heart Journal.

Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes
Pulit, S. L., Weng, L.-C., McArdle, P. F., Trinquart, L., Choi, S. H., Mitchell, B. D., … Sheth, K. (2018). Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes. NEUROLOGY-GENETICS, 4(6), e293.

Vitamin D with calcium supplementation and risk of atrial fibrillation in postmenopausal women.
Boursiquot, B. C., Larson, J. C., Shalash, O. A., Vitolins, M. Z., Soliman, E. Z., & Perez, M. V. (2018). Vitamin D with calcium supplementation and risk of atrial fibrillation in postmenopausal women. American Heart Journal, 209, 68–78.

Body composition and atrial fibrillation: a Mendelian randomization study.
Tikkanen, E., Gustafsson, S., Knowles, J. W., Perez, M., Burgess, S., & Ingelsson, E. (2019). Body composition and atrial fibrillation: a Mendelian randomization study. European Heart Journal.

No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation.
Harati, H., Zanetti, D., Rao, A., Gustafsson, S., Perez, M., Ingelsson, E., & Knowles, J. W. (2019). No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation. Diabetologia.

Comparison of QT Interval Measurement Methods and Correction Formulas in Atrial Fibrillation.
Tooley, J., Ouyang, D., Hadley, D., Turakhia, M., Wang, P., Ashley, E., … Perez, M. (2019). Comparison of QT Interval Measurement Methods and Correction Formulas in Atrial Fibrillation. The American Journal of Cardiology.

Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals.
Roberts, J. D., Hu, D., Heckbert, S. R., Alonso, A., Dewland, T. A., Vittinghoff, E., … Marcus, G. M. (2016). Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals. JAMA Cardiology, 1(4), 442–50.

Athletic Remodeling in Female College Athletes: The "Morganroth Hypothesis" Revisited.
Kooreman, Z., Giraldeau, G., Finocchiaro, G., Kobayashi, Y., Wheeler, M., Perez, M., … Haddad, F. (2019). Athletic Remodeling in Female College Athletes: The "Morganroth Hypothesis" Revisited. Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine, 29(3), 224–31.

No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation
Harati, H., Zanetti, D., Rao, A., Gustafsson, S., Perez, M., Ingelsson, E., & Knowles, J. W. (2019). No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation. DIABETOLOGIA, 62(5), 800–804.

Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study
Turakhia, M. P., Desai, M., Hedlin, H., Rajmane, A., Talati, N., Ferris, T., … Perez, M. V. (2019). Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study. AMERICAN HEART JOURNAL, 207, 66–75.

Comparison of QT Interval Measurement Methods and Correction Formulas in Atrial Fibrillation
Tooley, J., Ouyang, D., Hadley, D., Turakhia, M., Wang, P., Ashley, E., … Perez, M. (2019). Comparison of QT Interval Measurement Methods and Correction Formulas in Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 123(11), 1822–27.

Athletic Remodeling in Female College Athletes: The "Morganroth Hypothesis" Revisited
Kooreman, Z., Giraldeau, G., Finocchiaro, G., Kobayashi, Y., Wheeler, M., Perez, M., … Haddad, F. (2019). Athletic Remodeling in Female College Athletes: The "Morganroth Hypothesis" Revisited. CLINICAL JOURNAL OF SPORT MEDICINE, 29(3), 224–31.

Vitamin D with calcium supplementation and risk of atrial fibrillation in postmenopausal women
Boursiquot, B. C., Larson, J. C., Shalash, O. A., Vitolins, M. Z., Soliman, E. Z., & Perez, M. (2019). Vitamin D with calcium supplementation and risk of atrial fibrillation in postmenopausal women. AMERICAN HEART JOURNAL, 209, 68–78.

Broad Genetic Testing in a Clinical Setting Uncovers a High Prevalence of Titin Loss-of-Function Variants in Very Early-Onset Atrial Fibrillation.
Goodyer, W. R., Dunn, K., Caleshu, C., Jackson, M., Wylie, J., Moscarello, T., … Perez, M. (2019). Broad Genetic Testing in a Clinical Setting Uncovers a High Prevalence of Titin Loss-of-Function Variants in Very Early-Onset Atrial Fibrillation. Circulation. Genomic and Precision Medicine.

Body composition and atrial fibrillation: a Mendelian randomization study
Tikkanen, E., Gustafsson, S., Knowles, J. W., Perez, M., Burgess, S., & Ingelsson, E. (2019). Body composition and atrial fibrillation: a Mendelian randomization study. EUROPEAN HEART JOURNAL, 40(16), 1277-+.

Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation.
Perez, M. V., Mahaffey, K. W., Hedlin, H., Rumsfeld, J. S., Garcia, A., Ferris, T., … Turakhia, M. P. (2019). Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. The New England Journal of Medicine, 381(20), 1909–17.

Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study.
Larsson, S. C., Bäck, M., Rees, J. M., Mason, A. M., & Burgess, S. (2019). Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. European Heart Journal.

An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition.
Roberts, J. D., Asaki, S. Y., Mazzanti, A., Bos, J. M., Tuleta, I., Muir, A. R., … Ackerman, M. J. (2020). An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. Circulation.

An International, Multicentered, EvidenceBased Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome.
Adler, A., Novelli, V., Amin, A. S., Abiusi, E., Care, M., Nannenberg, E. A., … Gollob, M. H. (2020). An International, Multicentered, EvidenceBased Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation.

Apple Watch App Identifies Clinically Important Arrhythmias Other Than Atrial Fibrillation: Results From the Apple Heart Study
Perez, M. V., Mahaffey, K., Hedlin, H., Rumsfeld, J. S., Garcia, A., Ferris, T., … Turakhia, M. (2019). Apple Watch App Identifies Clinically Important Arrhythmias Other Than Atrial Fibrillation: Results From the Apple Heart Study. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS.

A Smartwatch to Identify Atrial Fibrillation. Reply.
Turakhia, M. P., Desai, M., & Perez, M. V. (2020). A Smartwatch to Identify Atrial Fibrillation. Reply. The New England Journal of Medicine, 382(10), 975–76.

A Smartwatch to Identify Atrial Fibrillation REPLY
Turakhia, M. P., Desai, M., & Perez, M. V. (2020). A Smartwatch to Identify Atrial Fibrillation REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 382(10), 975–76.

Exercise-induced right ventricular injury or arrhythmogenic cardiomyopathy (ACM): The bright side and the dark side of the moon.
Leischik, R., Strauss, M., Horlitz, M., Pareja-Galeano, H., de la Guía-Galipienso, F., Lippi, G., … Sanchis-Gomar, F. (2020). Exercise-induced right ventricular injury or arrhythmogenic cardiomyopathy (ACM): The bright side and the dark side of the moon. Progress in Cardiovascular Diseases.

Accuracy of Smartphone Camera Applications for Detecting Atrial Fibrillation: A Systematic Review and Meta-analysis.
O'Sullivan, J. W., Grigg, S., Crawford, W., Turakhia, M. P., Perez, M., Ingelsson, E., … Ashley, E. A. (2020). Accuracy of Smartphone Camera Applications for Detecting Atrial Fibrillation: A Systematic Review and Meta-analysis. JAMA Network Open, 3(4), e202064.

Artificial Intelligence and Machine Learning in Arrhythmias and Cardiac Electrophysiology.
Feeny, A. K., Chung, M. K., Madabhushi, A., Attia, Z. I., Cikes, M., Firouznia, M., … Wang, P. J. (2020). Artificial Intelligence and Machine Learning in Arrhythmias and Cardiac Electrophysiology. Circulation. Arrhythmia and Electrophysiology.

How Will Genetics Inform the Clinical Care of Atrial Fibrillation?
Shoemaker, M. B., Shah, R. L., Roden, D. M., & Perez, M. (2020). How Will Genetics Inform the Clinical Care of Atrial Fibrillation? CIRCULATION RESEARCH, 127(1), 111–27.

Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Sanchis-Gomar, F., Lavie, C. J., Morin, D. P., Perez-Quilis, C., Laukkanen, J. A., & Perez, M. V. (2020). Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection? American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions.

Genetic Determinants of Electrocardiographic P-wave Duration and Relation to Atrial Fibrillation.
Weng, L.-C., Hall, A. W., Choi, S. H., Jurgens, S. J., Haessler, J., Bihlmeyer, N. A., … Lubitz, S. A. (2020). Genetic Determinants of Electrocardiographic P-wave Duration and Relation to Atrial Fibrillation. Circulation. Genomic and Precision Medicine.

Apelin increases atrial conduction velocity, refractoriness, and prevents inducibility of atrial fibrillation.
Kim, Y. M., Lakin, R., Zhang, H., Liu, J., Sachedina, A., Singh, M., … Ashley, E. A. (2020). Apelin increases atrial conduction velocity, refractoriness, and prevents inducibility of atrial fibrillation. JCI Insight, 5(17).

Digital Health and the Care of the Arrhythmia Patient; What Every Electrophysiologist Needs to Know.
Tarakji, K. G., Silva, J. N., Chen, L. Y., Turakhia, M. P., Perez, M. V., Attia, Z. I., … Chung, M. K. (2020). Digital Health and the Care of the Arrhythmia Patient; What Every Electrophysiologist Needs to Know. Circulation. Arrhythmia and Electrophysiology.

Inherited causes of clonal haematopoiesis in 97,691 whole genomes.
Bick, A. G., Weinstock, J. S., Nandakumar, S. K., Fulco, C. P., Bao, E. L., Zekavat, S. M., … Natarajan, P. (2020). Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature.

Consumer wearable technologies to identify and monitor exercise-related arrhythmias in athletes.
Sanchis-Gomar, F., Lavie, C. J., & Perez, M. V. (2020). Consumer wearable technologies to identify and monitor exercise-related arrhythmias in athletes. Current Opinion in Cardiology.

Structural Abnormalities on Cardiac Magnetic Resonance Imaging in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
Gerber, D. A., Dubin, A. M., Ceresnak, S. R., Motonaga, K. S., Bussineau, M., Dunn, K., … Perez, M. V. (2020). Structural Abnormalities on Cardiac Magnetic Resonance Imaging in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia. JACC. Clinical Electrophysiology, 6(6), 741–42.

Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.
Benjamin, E. J., Go, A. S., Desvigne-Nickens, P., Anderson, C. D., Casadei, B., Chen, L. Y., … Al-Khatib, S. M. (2021). Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. Circulation, 143(4), 372–88.

Palpitations in an Elite Running Athlete: When to Run Through the Beat? A Case Report.
Giacomazzi, C., Diaz, R., Syrop, I., Perez, M., Froelicher, V. F., & Fredericson, M. (2021). Palpitations in an Elite Running Athlete: When to Run Through the Beat? A Case Report. Current Sports Medicine Reports, 20(2), 84–86.

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.
Taliun, D., Harris, D. N., Kessler, M. D., Carlson, J., Szpiech, Z. A., Torres, R., … Abecasis, G. R. (2021). Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature, 590(7845), 290–99.

Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene.
Jahng, J. W., Black, K. E., Liu, L., Bae, H. R., Perez, M., Ashley, E. A., … Wu, J. C. (2021). Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene. Stem Cell Research, 53, 102284.

Combining Clinical and Polygenic Risk Improves Stroke Prediction Among Individuals with Atrial Fibrillation.
O'Sullivan, J. W., Shcherbina, A., Justesen, J. M., Turakhia, M., Perez, M., Wand, H., … Ashley, E. A. (2021). Combining Clinical and Polygenic Risk Improves Stroke Prediction Among Individuals with Atrial Fibrillation. Circulation. Genomic and Precision Medicine.

Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.
Mondejar-Parreno, G., Jahng, J. W., Belbachir, N., Wu, B. C., Zhang, X., Perez, M. V., … Wu, J. C. (2021). Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome. Stem Cell Research, 54, 102402.

Management of Congenital Long-QT Syndrome: Commentary From the Experts.
Kaufman, E. S., Eckhardt, L. L., Ackerman, M. J., Aziz, P. F., Behr, E. R., Cerrone, M., … Zareba, W. (2021). Management of Congenital Long-QT Syndrome: Commentary From the Experts. Circulation. Arrhythmia and Electrophysiology, CIRCEP120009726.

Rare Coding Variants Associated with Electrocardiographic Intervals Identify Monogenic Arrhythmia Susceptibility Genes: A Multi-ancestry Analysis.
Choi, S. H., Jurgens, S. J., Haggerty, C. M., Hall, A. W., Halford, J. L., Morrill, V. N., … Lubitz, S. A. (2021). Rare Coding Variants Associated with Electrocardiographic Intervals Identify Monogenic Arrhythmia Susceptibility Genes: A Multi-ancestry Analysis. Circulation. Genomic and Precision Medicine.

Role of digital health in detection and management of atrial fibrillation.
Tooley, J. E., & Perez, M. V. (2021). Role of digital health in detection and management of atrial fibrillation. Heart (British Cardiac Society).

Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
Zhang, H., Jahng, J. W., Liu, Y., Chase, A. J., Perez, M. V., & Wu, J. C. (2021). Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene. Stem Cell Research, 55, 102492.

Exercise Effects On Cardiovascular Disease: From Basic Aspects To Clinical Evidence.
Sanchis-Gomar, F., Lavie, C. J., Marin, J., Perez-Quilis, C., Eijsvogels, T. M., O'Keefe, J. H., … Blair, S. N. (2021). Exercise Effects On Cardiovascular Disease: From Basic Aspects To Clinical Evidence. Cardiovascular Research.

Long-Term Exposures to Air Pollution and the Risk of Atrial Fibrillation in the Women's Health Initiative Cohort.
Hart, J. E., Hohensee, C., Laden, F., Holland, I., Whitsel, E. A., Wellenius, G. A., … Perez, M. V. (2021). Long-Term Exposures to Air Pollution and the Risk of Atrial Fibrillation in the Women's Health Initiative Cohort. Environmental Health Perspectives, 129(9), 97007.

Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death.
Walsh, R., Adler, A., Amin, A. S., Abiusi, E., Care, M., Bikker, H., … Gollob, M. H. (2021). Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death. European Heart Journal.

Arrhythmias Other Than Atrial Fibrillation in Those With an Irregular Pulse Detected With a Smartwatch: Findings From the Apple Heart Study.
Perino, A. C., Gummidipundi, S. E., Lee, J., Hedlin, H., Garcia, A., Ferris, T., … Perez, M. V. (2021). Arrhythmias Other Than Atrial Fibrillation in Those With an Irregular Pulse Detected With a Smartwatch: Findings From the Apple Heart Study. Circulation. Arrhythmia and Electrophysiology, CIRCEP121010063.

Epigenetic Age and the Risk of Incident Atrial Fibrillation.
Roberts, J. D., Vittinghoff, E., Lu, A. T., Alonso, A., Wang, B., Sitlani, C. M., … Marcus, G. M. (2021). Epigenetic Age and the Risk of Incident Atrial Fibrillation. Circulation.

Disruption of Protein Quality Control of Human Ether-a-go-go Related Gene K+ Channel Results in Profound Long QT Syndrome.
Ledford, H. A., Ren, L., Thai, P. N., Park, S., Timofeyev, V., Sirish, P., … Chiamvimonvat, N. (2021). Disruption of Protein Quality Control of Human Ether-a-go-go Related Gene K+ Channel Results in Profound Long QT Syndrome. Heart Rhythm.

Antiarrhythmic Drug Loading at Home Using Remote Monitoring: A Virtual Feasibility Study During COVID-19 Social Distancing
Shah, R. L., Kapoor, R., Bonnett, C., Ottoboni, L. K., Tacklind, C., Tsiperfal, A., & Perez, M. V. (2021). Antiarrhythmic Drug Loading at Home Using Remote Monitoring: A Virtual Feasibility Study During COVID-19 Social Distancing. European Heart Journal Digital Health.

Generation of two induced pluripotent stem cell lines from Brugada syndrome affected patients carrying SCN5A mutations.
Belbachir, N., Lai, C., Rhee, J.-W., Zhuge, Y., Perez, M. V., Sallam, K., & Wu, J. C. (2021). Generation of two induced pluripotent stem cell lines from Brugada syndrome affected patients carrying SCN5A mutations. Stem Cell Research, 57, 102605.

Sedentary Behavior and Atrial Fibrillation in Older Women: The OPACH Study.
Boursiquot, B. C., Bellettiere, J., LaMonte, M. J., LaCroix, A. Z., & Perez, M. V. (2022). Sedentary Behavior and Atrial Fibrillation in Older Women: The OPACH Study. Journal of the American Heart Association, e023833.

Lessons learned in the Apple Heart Study and implications for the data management of future digital clinical trials.
Garcia, A., Balasubramanian, V., Lee, J., Gardner, R., Gummidipundi, S., Hung, G., … Desai, M. (2022). Lessons learned in the Apple Heart Study and implications for the data management of future digital clinical trials. Journal of Biopharmaceutical Statistics, 1–15.

Getting Smart About Wearable ECG Interpretation in the Clinic.
Perez, M. V. (2022). Getting Smart About Wearable ECG Interpretation in the Clinic. JACC. Clinical Electrophysiology, 8(6), 792–794.

Contributions of the Women's Health Initiative to Cardiovascular Research: JACC State-of-the-Art Review.
LaMonte, M. J., Manson, J. A. E., Anderson, G. L., Baker, L. D., Bea, J. W., Eaton, C. B., … Rossouw, J. E. (2022). Contributions of the Women's Health Initiative to Cardiovascular Research: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 80(3), 256–275.

Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease.
Elias, P., Poterucha, T. J., Rajaram, V., Moller, L. M., Rodriguez, V., Bhave, S., … Perotte, A. J. (2022). Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease. Journal of the American College of Cardiology, 80(6), 613–626.

Premature ventricular contractions (PVCs) in young athletes.
Gomez, S. E., Hwang, C. E., Kim, D. S., Froelicher, V. F., Wheeler, M. T., & Perez, M. V. (2022). Premature ventricular contractions (PVCs) in young athletes. Progress in Cardiovascular Diseases.

Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.
Brandes, A., Stavrakis, S., Freedman, B., Antoniou, S., Boriani, G., Camm, A. J., … Turakhia, M. P. (2022). Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration. Circulation, 146(19), 1461–1474.

Serial 7-Day Electrocardiogram PatchScreening for AF inHigh-Risk Older Women by the CHARGE-AF Score.
Lin, J. Y., Larson, J., Schoenberg, J., Sepulveda, A., Tinker, L., Wheeler, M., … Perez, M. V. (2022). Serial 7-Day Electrocardiogram PatchScreening for AF inHigh-Risk Older Women by the CHARGE-AF Score. JACC. Clinical Electrophysiology, 8(12), 1523–1534.

The development of a mobile app-focused deduplication strategy for the Apple Heart Study that informs recommendations for future digital trials.
Garcia, A., Lee, J., Balasubramanian, V., Gardner, R., Gummidipundi, S. E., Hung, G., … Desai, M. (2022). The development of a mobile app-focused deduplication strategy for the Apple Heart Study that informs recommendations for future digital trials. Stat (International Statistical Institute), 11(1), e470.

Evaluation of the Association Between Circulating IL-1ß and Other Inflammatory Cytokines and Incident Atrial Fibrillation in a Cohort of Postmenopausal Women.
Gomez, S. E., Parizo, J., Ermakov, S., Larson, J., Wallace, R., Assimes, T., … Perez, M. V. (2023). Evaluation of the Association Between Circulating IL-1ß and Other Inflammatory Cytokines and Incident Atrial Fibrillation in a Cohort of Postmenopausal Women. American Heart Journal.

Multimodal deep learning enhances diagnostic precision in left ventricular hypertrophy.
Soto, J. T., Weston Hughes, J., Sanchez, P. A., Perez, M., Ouyang, D., & Ashley, E. A. (2022). Multimodal deep learning enhances diagnostic precision in left ventricular hypertrophy. European Heart Journal. Digital Health, 3(3), 380–389.

Using wearables to manage atrial fibrillation: Pushing the boundaries with consumer devices.
Perez, M. V. (2023). Using wearables to manage atrial fibrillation: Pushing the boundaries with consumer devices. Journal of Cardiovascular Electrophysiology.

Antiarrhythmic drug loading at home using remote monitoring: a virtual feasibility study during COVID-19 social distancing.
Shah, R. L., Kapoor, R., Bonnett, C., Ottoboni, L. K., Tacklind, C., Tsiperfal, A., & Perez, M. V. (2021). Antiarrhythmic drug loading at home using remote monitoring: a virtual feasibility study during COVID-19 social distancing. European Heart Journal. Digital Health, 2(2), 259–262.

Arrhythmogenic Cardiomyopathy and Athletes - A Dangerous Relationship.
de la Guía-Galipienso, F., Ugedo-Alzaga, K., Grazioli, G., Quesada-Ocete, F. J., Feliu-Rey, E., Perez, M. V., … Sanchis-Gomar, F. (2023). Arrhythmogenic Cardiomyopathy and Athletes - A Dangerous Relationship. Current Problems in Cardiology, 101799.

Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy.
Lampert, R., Ackerman, M. J., Marino, B. S., Burg, M., Ainsworth, B., Salberg, L., … Day, S. M. (2023). Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. JAMA Cardiology.

Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations.
Kong, X., Belbachir, N., Zeng, W., Yan, C. D., Navada, S., Perez, M. V., & Wu, J. C. (2023). Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations. Stem Cell Research, 69, 103111.

Expanding the stdpopsim species catalog, and lessons learned for realistic genome simulations.
Lauterbur, M. E., Cavassim, M. I., Gladstein, A. L., Gower, G., Pope, N. S., Tsambos, G., … Gronau, I. (2023). Expanding the stdpopsim species catalog, and lessons learned for realistic genome simulations. ELife, 12.

From Founder to Function: can we unravel phenotype from genotype?
Weldy, C. S., & Perez, M. V. (2023). From Founder to Function: can we unravel phenotype from genotype? Heart Rhythm.

Association Between Insomnia, Stress Events, and Other Psychosocial Factors and Incident Atrial Fibrillation in Postmenopausal Women: Insights From the Women's Health Initiative.
Zhao, S. X., Tindle, H. A., Larson, J. C., Woods, N. F., Crawford, M. H., Hoover, V., … Perez, M. V. (2023). Association Between Insomnia, Stress Events, and Other Psychosocial Factors and Incident Atrial Fibrillation in Postmenopausal Women: Insights From the Women's Health Initiative. Journal of the American Heart Association, e030030.

A deep learning-based electrocardiogram risk score for long term cardiovascular death and disease.
Hughes, J. W., Tooley, J., Torres Soto, J., Ostropolets, A., Poterucha, T., Christensen, M. K., … Perez, M. V. (2023). A deep learning-based electrocardiogram risk score for long term cardiovascular death and disease. NPJ Digital Medicine, 6(1), 169.

Development and validation of a rapid visual technique for left ventricular hypertrophy detection from the electrocardiogram.
Somani, S., Hughes, J. W., Ashley, E. A., Witteles, R. M., & Perez, M. V. (2023). Development and validation of a rapid visual technique for left ventricular hypertrophy detection from the electrocardiogram. Frontiers in Cardiovascular Medicine, 10, 1251511.

The evolving role of data & safety monitoring boards for real-world clinical trials.
Bunning, B. J., Hedlin, H., Chen, J. H., Ciolino, J. D., Ferstad, J. O., Fox, E., … Desai, M. (2023). The evolving role of data & safety monitoring boards for real-world clinical trials. Journal of Clinical and Translational Science, 7(1), e179.

Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-ß-Blocking R-Enantiomer Carvedilol.
Seo, K., Yamamoto, Y., Kirillova, A., Kawana, M., Yadav, S., Huang, Y., … Ashley, E. A. (2023). Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-ß-Blocking R-Enantiomer Carvedilol. Circulation.

Electrocardiographic deep learning for predicting post-procedural mortality: a model development and validation study.
Ouyang, D., Theurer, J., Stein, N. R., Hughes, J. W., Elias, P., He, B., … Albert, C. M. (2023). Electrocardiographic deep learning for predicting post-procedural mortality: a model development and validation study. The Lancet. Digital Health.

Utility of smart watches for identifying arrhythmias in children.
Zahedivash, A., Chubb, H., Giacone, H., Boramanand, N. K., Dubin, A. M., Trela, A., … Ceresnak, S. R. (2023). Utility of smart watches for identifying arrhythmias in children. Communications Medicine, 3(1), 167.

Clinical Management of Brugada Syndrome: Commentary From the Experts.
Cutler, M. J., Eckhardt, L. L., Kaufman, E. S., Arbelo, E., Behr, E. R., Brugada, P., … Wilde, A. A. (2023). Clinical Management of Brugada Syndrome: Commentary From the Experts. Circulation. Arrhythmia and Electrophysiology, e012072.

Race, Sex, and Age Disparities in the Performance of ECG Deep Learning Models Predicting Heart Failure.
Kaur, D., Hughes, J. W., Rogers, A. J., Kang, G., Narayan, S. M., Ashley, E. A., & Perez, M. V. (2023). Race, Sex, and Age Disparities in the Performance of ECG Deep Learning Models Predicting Heart Failure. Circulation. Heart Failure, e010879.

Arrhythmias including Atrial Fibrillation and Congenital Heart Disease in Kleefstra Syndrome: a possible epigenetic link.
Vasireddi, S. K., Draksler, T. Z., Bouman, A., Kummeling, J., Wheeler, M., Reuter, C., … Perez, M. V. (2024). Arrhythmias including Atrial Fibrillation and Congenital Heart Disease in Kleefstra Syndrome: a possible epigenetic link. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology.

Maladaptive versus adaptative cardiovascular phenotype in response to exercise training: Expert opinion of the evidence
Sanchis-Gomar, F., Perez-Quilis, C., Eijsvogels, T. M. H., Guia-Galipienso, F. D. la, Christle, J. W., Perez, M. V., & Lavie, C. J. (2023). Maladaptive versus adaptative cardiovascular phenotype in response to exercise training: Expert opinion of the evidence. HEART AND MIND, 7(2), 57–61.

Prevalence of frequent premature ventricular contractions and nonsustained ventricular tachycardia in older women screened for atrial fibrillation in the Women's Health Initiative.
Gomez, S. E., Larson, J., Hlatky, M. A., Rodriguez, F., Wheeler, M., Greenland, P., … Perez, M. V. (2024). Prevalence of frequent premature ventricular contractions and nonsustained ventricular tachycardia in older women screened for atrial fibrillation in the Women's Health Initiative. Heart Rhythm.

Expedited Loading with Intravenous Sotalol is Safe and Feasible - Primary Results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry.
Steinberg, B. A., Holubkov, R., Deering, T., Groh, C. A., Mittal, S., Kennedy, R., … Bunch, T. J. (2024). Expedited Loading with Intravenous Sotalol is Safe and Feasible - Primary Results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry. Heart Rhythm.

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., … Van Wagoner, D. R. (2024). 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. CIRCULATION, 149(1), e1–e156.

Characteristics of Contemporary Atrial Fibrillation Clinical Trials and Their Association With Industry Sponsorship.
Lan, R. H., Paranjpe, I., Saeed, M., & Perez, M. V. (2024). Characteristics of Contemporary Atrial Fibrillation Clinical Trials and Their Association With Industry Sponsorship. Heart Rhythm.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Closed Trials

Practice Locations

Cardiac Arrhythmia Service at Palo Alto Stanford, CA

Stanford, CA

5.0/5

Explanations

5.0/5

Listens

5.0/5

Care provider's efforts to include you in decisions about your care

5.0/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(90 reviews)

Excellent person and physician. I feel fortunate to have him. He is working WITH me.

Jun 2024

•

Verified SHC Patient

I am very thankful for the time he took to clearly explain the options and answer my questions. I never felt rushed during the visit. I am very happy with him and his entire team and the care they provide.

May 2024

•

Verified SHC Patient

Dr. Perez is very kind, knowledgeable, caring and also very well at communicating. Our questions are always answered, I am very happy to have Dr. Perez care for my hearth

Apr 2024

•

Verified SHC Patient

Excellent Dr. your explanations are very easy to understand. You answered all my questions n then some. Very charming n easy to talk to.

Mar 2024

•

Verified SHC Patient

Very engaging and friendly. Felt he was interested in our familyâ€™s best interests.

Feb 2024

•

Verified SHC Patient

Dr. Perez is an outstanding person Very sharp, well educated filled with kindness and compassion for his patients I am so thankful to be cared by him, because I can always count on him on finding the best solution or steps we should take to help my heart function at its capacity Thank you Dr. Perez for all your help and support

Feb 2024

•

Verified SHC Patient

Dr. Perez read my case and has an understanding of where I stand with my defibrillator.

Jan 2024

•

Verified SHC Patient

Excellent

Jan 2024

•

Verified SHC Patient

Iâ€™m a big fan. Communicative, empathetic

Jan 2024

•

Verified SHC Patient

Excellent doctor - explained everything well, was patient with my questions.

Nov 2023

•

Verified SHC Patient

I can say that I was extremely pleased with my video visit with Dr. Marco Perez. Since the start of our conversation, I could see that he was a very skilled professional that was very knowledgeable in the field of cardiovascular medicine. Before the start of our video, he had reviewed all my medical history and explained to me very clearly the purpose of our visit and the various options available for treating my atrial fibrillation. He treated me very well, with respect and compassion, and answered all my questions and concerns in a way that I could understand without leaving any doubts. Great experience!

Aug 2023

•

Verified SHC Patient

Marco Perez answered all my questions about the upcoming procedure, and assured me that this was the best possible solution to my afib.

Aug 2023

•

Verified SHC Patient

Very professional, knowledgable and reassuring. Explained everything well and answered all my questions patiently.

May 2023

•

Verified SHC Patient

He. And the rest of his team are great!

May 2023

•

Verified SHC Patient

Dr. Perez took the time to listen to my concerns and was very thorough in explaining things. I didnâ€™t feel rushed. He showed that he cared for me as a patient.

Apr 2023

•

Verified SHC Patient

Personable, respectful, thorough, kind and efficient.

Apr 2023

•

Verified SHC Patient

Look forward to an in person meeting.

Mar 2023

•

Verified SHC Patient

Thank you!

Mar 2023

•

Verified SHC Patient

He was very informative and pleasant. I trust that his knowledge is accurate and it allows me to make informative decisions about my health.

Feb 2023

•

Verified SHC Patient

Dr. Perez is very thorough & asks if there was any concerns. Thank you Dr. Perez & the staff at the Cardiology department.

Feb 2023

•

Verified SHC Patient

Dr Perez is very friendly and caring.

Jan 2023

•

Verified SHC Patient

He is excellent.

Oct 2022

•

Verified SHC Patient

Easy to talk to. Answered all my questions and was very informative.

Sep 2022

•

Verified SHC Patient

Very clear explanations

Sep 2022

•

Verified SHC Patient

Excellent patient manner. Seemed to be prepared and was straight-forward about his views and the next steps.

Sep 2022

•

Verified SHC Patient

Excellent doctor

Jun 2022

•

Verified SHC Patient

He was looking down most of the time. Would be good to figure out his video setup so that it looks more like he is looking at me.

May 2022

•

Verified SHC Patient

Great Doctor. Well spoken and knowledgeable.

Apr 2022

•

Verified SHC Patient

Dr. Perez has been very helpful and a great doctor with my situation. Between the unknown of procedures, symptoms, & all the medical conditions that arise with Cardiology, Dr.Perez has given me the utmost importance in my case. I want to Thank him, his Staff, Surgery staff, & everyone at Stanford for the excellent care & treatment. Thank you Dr.Perez, I truly am grateful for everything!

Apr 2022

•

Verified SHC Patient

Stellar care.

Mar 2022

•

Verified SHC Patient

I know I am in good hands. Thank you

Mar 2022

•

Verified SHC Patient

I always enjoy my appointments with Dr. Perez. He is a wonderful doctor.

Feb 2022

•

Verified SHC Patient

Dr. Perez was very thorough asking questions about my condition and provided detailed answers to all my questions. I really recommend Dr. Perez as a great specialist.

Feb 2022

•

Verified SHC Patient

All good - thank you

Feb 2022

•

Verified SHC Patient

Dr Perez has been my EP for some time. Dr Perez takes time and explains everything fully and answers all my questions

Feb 2022

•

Verified SHC Patient

Dr. Perez is a very caring doctor that has the patients best interests. Always going beyond. Thanks!

Jan 2022

•

Verified SHC Patient

Very nice guy and he seems like he genuinely cares about his patients. Would definitely recommend him to others.

Jan 2022

•

Verified SHC Patient

Thank you

Jan 2022

•

Verified SHC Patient

He was very attentive and answered all my questions.

Dec 2021

•

Verified SHC Patient

I would like to say that I am so very grateful to be under the care of Dr. Marco Perez. He is such a wonderful man, and physician! I could not feel better taken care of, and more cared about by a Dr.. Stanford and his patients are incredibly lucky to have him. As am I. I hope that these sentiments are read someone passes them on to him. Joshua VaMetre

Dec 2021

•

Verified SHC Patient

Dr. Perez and his team were very helpful and knowledgeable. Very impressed.

Oct 2021

•

Verified SHC Patient

Very personible, very clear with information, fully explained the procedure and alternative treatments. Very kind, liked him very much.

Oct 2021

•

Verified SHC Patient

Good rapport. Got me relaxed so that we could talk about my healthcare needs. A lot of medicine is really listening before diagnosis...he seems to be good at that.

Aug 2021

•

Verified SHC Patient

Communication was excellent! Listened well to my concerns, explained things in detail, and maintained professionalism. Appeared genuinely concerned about my care.

Aug 2021

•

Verified SHC Patient

Affable, professional, listened, informed about my case, offered clear advice

Aug 2021

•

Verified SHC Patient

He is very good about answering my questions and listening to my concerns.

Aug 2021

•

Verified SHC Patient

Excellent video call manner. Very clear, very kind and answered all my questions.

Jul 2021

•

Verified SHC Patient

Dr Perez is the best

Jul 2021

•

Verified SHC Patient

He is amazing! Brilliant, patient, and kind.

Jul 2021

•

Verified SHC Patient

Very happy with willingness to explain and answer. Never felt like we were rushed. He took the time to make sure we understood our options.

Jun 2021

•

Verified SHC Patient

Dr Perez is fantastic. Every appt I feel like he listens and provides his expertise in helping me improve my quality of life

May 2021

•

Verified SHC Patient

pleasant, informative, inspires confidence.

May 2021

•

Verified SHC Patient

Very pleased and impressed by our first visit!

May 2021

•

Verified SHC Patient

I am so happy to have Dr. Perez as my cardiologist. He is very kind and thorough, and has amazing nurses. I love working with Colleen and Allysonne- they are the best!

May 2021

•

Verified SHC Patient

Very thorough. He listened to my questions and concerns and addressed them thoughtfully.

May 2021

•

Verified SHC Patient

Everybody did a great job, but especially I would like to mention his Colleen Caleshu and her team.

Jun 2019

•

Verified SHC Patient

Dr. Marco Perez is one of the best physicians I've experienced.

Apr 2018

•

Verified SHC Patient

Healthcare all around the world was charged drastically over the last 20 years. People became care providers because they had a passion to help others. As a society we do not take good care of ourselves. The need for good, compassionate healthcare providers is at an all time high but there are to many people pursuing healthcare for a career and not because they have a calling. I live in a small town just under 100,000 people and most of the physicians in Chico, CA treat you like cattle than a person. It's because of these experiences many people, like me, do not seek out answers/care to they're HC problems. I've only had 3 appt. @ Stanford and each time I am there I am treated with dignity and respect. To value me, like this, allows me to relax and trust the system Stanford has in place. Keep it up!

Jan 2018

•

Verified SHC Patient

Amazing!!! Hard to describe the level of intelligence, kindness and relatability.

Jan 2018

•

Verified SHC Patient

Dr. Perez is an excellent physician. I trust him with my care.

Nov 2017

•

Verified SHC Patient

Doctor was excellent and spent plenty of time describing my options for future care.

Oct 2017

•

Verified SHC Patient

Dr. Perez is outstanding!

Sep 2017

•

Verified SHC Patient

Dr. Perez listened to my unusual side effects to medication/Toprol XL. He was considerate and obliging to my request to try to get off med & try a heart monitor (Zio monitor).

Sep 2017

•

Verified SHC Patient

Dr. Perez always spends plenty of time with us. Never hurries us.

Aug 2017

•

Verified SHC Patient

Dr. Perez is a "10"!

Jun 2017

•

Verified SHC Patient

Loved Dr. Perez and his team - I felt very comfortable, and like they truly cared.

May 2017

•

Verified SHC Patient

Dr. Perez was the very best.

Apr 2017

•

Verified SHC Patient

I've the highest respect for the care I've been given by Dr. Marco Perez & his NP Allysone Smith. They are both highly skilled, very friendly & caring, and I can't say enough good about them.

Jan 2017

•

Verified SHC Patient

Excellent beyond expectation.

Dec 2016

•

Verified SHC Patient

Good.

Dec 2016

•

Verified SHC Patient

Everything was great but I was told I would get a call to go over lab results and I'm still waiting I send an e-mail and have not heard back. I have the results on "my health" but I don't know or understand what it all means.

Oct 2016

•

Verified SHC Patient

Dr. Perez is one of the best, most competent, knowledgeable doctors I have ever visited. He has given me excellent care these last close to 2 yrs. I will miss him!

Aug 2016

•

Verified SHC Patient

Good experience - doctor was great! Just took too long to get to him as a new pt.

Aug 2016

•

Verified SHC Patient

always very helpful

Jul 2016

•

Verified SHC Patient

Kate was wonderful again. She carefully explained my condition to me, my progression and further treatment and visits in the future. She really took the time to address my concerns.

Jul 2016

•

Verified SHC Patient

I get the best care from Dr. Perez - I call him my miracle worker. He & his staff cured my arrythmia. My heart now beats at regularly.

Jul 2016

•

Verified SHC Patient

Dr. Perez has helped me through my ICD process and getting used to it. And answers my questions regarding it.

May 2016

•

Verified SHC Patient

Love Dr. Perez & his team. Alyson is great.

Mar 2016

•

Verified SHC Patient

Dr Perez came to see me and talk to me a number of times when I was in the hospital for a week in July. he is a very compassionate person.

Nov 2015

•

Verified SHC Patient

Great professional. Considerate and listens

Oct 2015

•

Verified SHC Patient

spent an hour with my husband and I answering questionsvery compassionate

Aug 2015

•

Verified SHC Patient

Very impressed with Dr. Perez - - he knew my health history - - it was a 1st of documents to review.

Jun 2015

•

Verified SHC Patient

Dr. was very kind and understanding.

Jun 2015

•

Verified SHC Patient

Every person I know that wonders how I am I tell Stanford Hosp. is the very best hosp. I have ever been too.

Apr 2015

•

Verified SHC Patient

Dr. Perez is also very professional & courteous.

Mar 2015

•

Verified SHC Patient

Excellent professional, friendly, knowledgeable, care provider.

Feb 2015

•

Verified SHC Patient

Dr. Marco & nurse Alison are very caring and compassionate. Alison is amazing in her quick response times.

Jul 2014

•

Verified SHC Patient

Never write on comments BUT Doc Perez and his staff is worth it!

Jul 2014

•

Verified SHC Patient

Dr. Perez was excellent in categories.

Apr 2014

•

Verified SHC Patient

Good experience overall.

Feb 2014

•

Verified SHC Patient

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Marco Perez

Cardiac electrophysiologist

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Cardiac Arrhythmia Service at Palo Alto Stanford, CA

Cardiac Arrhythmia Service at Palo Alto

Hypertrophic Cardiomyopathy Center Stanford, CA

Hypertrophic Cardiomyopathy Center

Stanford Sports Cardiology Stanford, CA

Stanford Sports Cardiology

Center for Inherited Cardiovascular Disease at Stanford Stanford, CA

Center for Inherited Cardiovascular Disease at Stanford

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(90 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Marco Perez

Cardiac electrophysiologist

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Cardiac Arrhythmia Service at Palo Alto Stanford, CA

Cardiac Arrhythmia Service at Palo Alto

Hypertrophic Cardiomyopathy Center Stanford, CA

Hypertrophic Cardiomyopathy Center

Stanford Sports Cardiology Stanford, CA

Stanford Sports Cardiology

Center for Inherited Cardiovascular Disease at Stanford Stanford, CA

Center for Inherited Cardiovascular Disease at Stanford

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(90 reviews)

Referring Physicians

PHYSICIAN HELPLINE